natap.org Show on alexa natap.org
Redirect to natap.orgdelete
National AIDS Treatment Advocacy Project - NATAP - HIV - AIDS Treatment Information
Local position
374 097
374 097
Global position
765 491
Society » Issues » Health » Conditions and Diseases » Sexually Transmitted Diseases » AIDS » Treatment Activism » Organizations
Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Regional » North America » United States » New York
Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Treatment and Therapies
United States » Society » Issues » Health » Conditions and Diseases » Sexually Transmitted Diseases » AIDS » Treatment Activism » Organizations
United States » Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Regional » North America » United States » New York
United States » Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Treatment and Therapies
-
-
Unique daily visits 764Unique daily views 993
- Observe
-
Average load page noneIP address 216.92.100.202Last update website 11 years ago
-
Alexa rank from last month (top 1m)
Chart of the last 30 days Chart of the last 3 months Chart of the last 6 months Chart of the last yearCompare natap.org to:
-
Which websites did users visit before enter the natap.org
google.com 39.13% -
Which websites did users visit after leaving the natap.org
google.com 38.10% -
Pages indexed at
Yahoo 35Bing 33 -
Backlinks
Yahoo noneBing noneAlexa 626 -
Social media
Facebook 47Twitter 17 -
Site info
TitleNational AIDS Treatment Advocacy Project - NATAP - HIV - AIDS Treatment Information
DescriptionNatap's web site is a leader in up-to-the minute HIV treatment information, covering the latest in drug development and research, comprehensive conference reports, and in-depth articles on HIV treatments. NATAP's newsletter, Protease Inhibitor User's Guide, and other publications are all available on the site
Keywordsprotease inhibitors, HIV, AIDS, treatment, Hep C, hepatitis, Hepatitis C, HCV, coinfection, co-infection, IVDU, peg-intron, Interferon, liver, Ribavirin, Pegylated Interferon, Pegasys, genotype, experimental, nucleosides, non-nucleosides, drug therapies, HIV drugs, adherence, compliance, viral load, 50 copies, proviral DNA, RNA, 4 drugs, Efavirenz, DMP-266, salvage therapy, 1592U89, Abacavir, t-20, fusion inhibitor, PMEA, MKC-442, resistance, double protease, Crixivan, indinavir, Viracept, nelfi